Veraliprida y rimonabant

Veraliprida y rimonabant

Bibliographic Details
Main Author:	Flavia Vidal
Format:	Article
Language:	Spanish
Published:	Fundacion MF 2007-09-01
Series:	Evidencia. Actualización en la Práctica Ambulatoria
Online Access:	http://www.evidencia.org.ar/index.php/Evidencia/article/view/5648

Similar Items

Rimonabant: From RIO to Ban
by: Amir H. Sam, et al.
Published: (2011-01-01)

Rimonabant for treating tobacco dependence
by: Michael B Steinberg, et al.
Published: (2007-07-01)

Rimonabant for the treatment of overweight and obese people
by: J Burch, et al.
Published: (2009-10-01)

The effect of rimonabant and gender on lipid kinetics in obesity
by: Sarac, Ivana
Published: (2013)

Rimonabant dimorphism, much ado about almost nothing
by: Perrin M.-A., et al.
Published: (2013-07-01)

EFFECTS OF RIMONABANT ON ACTIVE AVOIDANCE LEARNING IN BULBECTOMIZED RATS
by: Margarita Velikova
Published: (2020-02-01)

Effects of Combined Oleoyl-Estrone and Rimonabant on Overweight Rats
by: Raquel Ferrer-Lorente, et al.
Published: (2007-01-01)

Discriminative stimulus properties of 3-substituent rimonabant analogs
by: Walentiny, D. Matthew
Published: (2011)

The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant
by: Murro Ada
Published: (2009-10-01)

Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results
by: Fernández-Fernández C, et al.
Published: (2014-02-01)

The psychiatric side-effects of rimonabant Os efeitos-colaterais psiquiátricos do rimonabanto
by: Fabrício A. Moreira, et al.
Published: (2009-06-01)

Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease
by: Bojan Jorgačević, et al.
Published: (2015-01-01)

The modulatory effects of rimonabant and retrieval-extinction procedures on cocaine-associated memory in mice
by: Heng-AiChang, et al.
Published: (2016)

Untersuchung von Topiramat, Rimonabant, Orlistat und neuer Forschungschemikalien in verschiedenen Fettsuchtmodellen an Ratten
by: Hagn, Magdalena
Published: (2007)

RP-HPLC Method Development and Its Validation for Quantitative Determination of Rimonabant in Human Plasma
by: Shravan Bankey, et al.
Published: (2012-01-01)

The effect of gender and rimonabant on energy expenditure, gene expression and body fat distribution in obesity
by: Backhouse, Katharine
Published: (2010)

Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids
by: Donatella Fiore, et al.
Published: (2018-01-01)

The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol
by: José Antonio López-Moreno, et al.
Published: (2007-02-01)

Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology
by: Crocè Lory S, et al.
Published: (2009-10-01)

Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
by: Carine Poussin, et al.
Published: (2008-01-01)

The effects of weight loss using dietary manipulation and rimonabant therapy on arterial stiffness in type 2 diabetes
by: A. Chakera, et al.
Published: (2010-04-01)

Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling
by: Stefan Almestrand, et al.
Published: (2015-06-01)

Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice.
by: Chunxiu Hu, et al.
Published: (2011-01-01)

Modulatory effects on rimonabant on cocaine-associated memory: roles of sex difference and corticosterone and medial prefrontal dopaminergic receptors
by: Mei-LingLai, et al.
Published: (2018)

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
by: Adriano Mollica, et al.
Published: (2017-01-01)

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
by: Kirk A Bronander, et al.
Published: (2007-05-01)

Effects of the cannabinoid CB1 receptor antagonist rimonabant on consolidation, reconsolidation, and forced extinction of cocaine-associated memory
by: Ya-WeiLiu, et al.
Published: (2014)

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
by: Li Zhao, et al.
Published: (2021-04-01)

Einfluss der Langzeittherapie mit dem Endocannabinoid-Rezeptorblocker Rimonabant auf Thrombozytenaktivierung und proinflammatorische Chemokine bei Diabetes
by: Neumüller, Jutta
Published: (2010)

An in Vitro investigation of the effects of Rimonabant (a cannabinoid CB1 receptor antagonist) on cell adhesion and inflammatory associated cytokine production
by: Bouwer, Adoree
Published: (2013)

CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)
by: Günter A. Müller, et al.
Published: (2020-02-01)

P1.09 THE EFFECTS OF RIMONABANT-INDUCED WEIGHT LOSS ON ARTERIAL FUNCTION AND GLYCAEMIA IN OBESE ADULTS WITH TYPE 2 DIABETES
by: A.J. Chakera, et al.
Published: (2008-09-01)

Einfluss der Kurzzeittherapie mit dem Cannabinoid-1-Rezeptorantagonisten Rimonabant auf Thrombozytenaktivierung und proinflammatorische Chemokine bei Diabetes mellitus
by: Fiedler, Stefanie
Published: (2011)

Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice
by: B. Chen, et al.

Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant
by: Heppenstall Charlotte, et al.
Published: (2012-07-01)

Comparison of rimonabant and sibutramine treatment effects on food compulsion in rats Comparação do efeito do rimonabanto e da sibutramina no tratamento da compulsão alimentar em ratos
by: Honório Sampaio Menezes, et al.
Published: (2009-12-01)

High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain
by: Edward T. Wargent, et al.
Published: (2020-08-01)

Suspensión de la comercialización de carisoprodol en España
by: Flavia Vidal
Published: (2008-03-01)

A escolha vivida: um estudo antropológico sobre a relação entre a escolha do método anticoncepcional e as outras dimensões da vida de mulheres que participam dos grupos de educação em saúde
by: Magalhães, Flávia Vidal
Published: (2016)

Patrones didácticos y pedagógicos para consolidar la educación
by: Enrique Vidal Vidal
Published: (2008-04-01)